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Abstract
Background: Staphylococcus aureus remains a medical challenge in the treatment of bacterial infections. It has
acquired resistance to commonly used antibiotics, and to those considered to be the last weapons in treating
staphylococcal infections, such as vancomycin. Studies have revealed that S. aureus is capable of mounting a rapid
response to antibiotics that target cell wall peptidoglycan biosynthesis, such as β-lactams and vancomycin. The
two-component system VraSR has been linked to the coordination of this response. VraS is a histidine kinase that
undergoes autophosphorylation in the presence of signals elicited upon cell wall damage and it then transfers its
phosphoryl group to VraR. VraR is a response regulator protein that functions as a transcription factor.
Phosphorylation of VraR leads to its dimerization, which is required for optimum binding to its target promoters.
Two-component systems have been targeted for the development of antibacterial agents. Deletion of the vraS or
vraR gene has been shown to re-sensitize S. aureus to β-lactams and vancomycin.
Results: In this study, we explored perturbation of the VraR phosphorylation-induced activation as a means to
inhibit the VraSR-mediated signal transduction pathway. We show that dimerization of VraR is essential for the
phosphorylation-induced activation of VraR. A single point mutation in the dimerization interface of VraR, in
which Met13 was replaced by Ala, led to the inability of VraR to dimerize and to bind optimally to the target
promoter. The consequences of these in vitro molecular deficiencies are equally dramatic in vivo.
Complementation of a vraR deletion S. aureus strain with the vraRM13Ala mutant gene failed to induce the
cell wall stress response.
Conclusions: This study highlights the potential of targeting the phosphorylation-induced dimerization of VraR to
disrupt the S. aureus cell wall stress response and in turn to re-sensitize S. aureus to β-lactams and vancomycin.
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Background
Two-component signaling systems (TCSs) are prevalent
in bacteria [1, 2]. They enable coupling of a diverse array
of adaptive responses to environmental stimuli including
antibiotic stress [1, 3]. Their absence in high eukaryotic
systems makes them a prime target for development of
novel antimicrobial agents [4]. Signaling via TCSs is
based on a conserved phosphor transfer process between
a histidine kinase (HK) and a response regulator protein
(RR) (Fig. 1). The output response is controlled by the
RR, which plays the role of a phosphorylation-activated
switch [5]. About 60% of all identified RRs act as tran-
scription factors [5].
The vancomycin-resistance-associated response regula-
tor protein, VraR, and its cognate histidine kinase, VraS,
constitute a two-component system in Staphylococcus
aureus (Fig. 1a) that has been shown to mediate resistance
to β-lactams and vancomycin [6]. VraSR has gained atten-
tion as a potential target in encountering the antibiotic re-
sistance in multiple antibiotic resistant S. aureus strains
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such as MRSA. Deletions within the vraSR operon re-
sensitize MRSA strains to β-lactams and vancomycin [7–
11]. The VraSR-mediated signal transduction pathway is
activated by the exposure of S. aureus to antibiotics and
gene deletions that inhibit cell wall synthesis [6, 12, 13].
Cell wall damage in S. aureus leads to the VraR-dependent
regulation of more than 40 genes [6]. However, the precise
nature of the signal(s) that turns on the VraSR-mediated
signaling pathway is not known. Both VraS and VraR are
multidomain proteins (Fig. 1a). VraS consists of an N-
terminal transmembrane domain, which, in a number of
histidine kinases, is involved in sensing the extracellular
stimuli, and a C-terminal core domain that harbors the
dimerization interface, the conserved histidine residue,
and the ATP-binding domain. VraR consist of a conserved
N-terminal domain that harbors the phosphorylation site,
referred to as the regulator domain (RD), and a variable
C-terminal domain that interacts with DNA, referred to
as the effector domain (ED) (Fig. 1a). Upon cellular stress,
VraS is activated through an autophosphorylation event
(t1/2 ~ 10min) [12, 14]. Subsequently, the histidine kinase
transfers the phosphoryl group, almost instantaneously (t1/2
~ 10 s), onto VraR [14]. Upon its phosphorylation, VraR di-
merizes at the N-terminal domain. Phosphorylation-
induced dimerization is shown to expand and enhance the
VraR binding to its own promoter (Fig. 1b) [14–16], and,
consequently, to increase the expression of the vraSR op-
eron [17]. Higher vraR expression leads to modulation of
as many as 40 genes, which ultimately constitute the S. aur-
eus response to cell wall damage. The VraSR-mediated sig-
nal transduction is reset in the absence of stress through
the phosphatase activity of VraS toward VraR [14].
The events that lead to the phosphorylation-induced
dimerization of VraR have been elucidated by hydrogen-
deuterium mass spectrometry and X-ray crystallography
[16, 18]. These studies showed occurrence of structural re-
arrangement in the VraR regulator domain in the phos-
phorylated dimeric species. In particular, the crystal
structure showed that these structural rearrangements ul-
timately are associated with the formation of a hydrophobic
pocket that wraps snugly the side chain of a methionine
residue, Met13, which protrudes from an α-helix region (α1
helix) of the opposing protomer in the dimer complex
(Fig. 2) [16]. This discovery provided a strategy for the
targeting of two-component signal transduction path-
ways, that of inhibition of the phosphorylation-induced
dimerization of RR.
VraR belongs to the NarL/FixJ family of RR, which use
the helix-turn-helix motif to bind to DNA. The
dimerization interface found in VraR is seen in a subset
of this family of proteins, for example in Escherichia coli
UhpA [19], a response regulator that regulates sugar up-
take, Mycobacterium tuberculosis NarL [20], S. aureus
LuxR (PDB ID 3B2N), a response regulator implicated in
regulation of cell-density, Bacillus subtillis DesR [21],
and Enterococcus faecium LiaR, a response regulator in-
volved in daptomycin induced cell wall stress response
[22]. The response regulator proteins that belong to the
OmpR/PhoB family of proteins, which use a winged
helix-turn-helix to target DNA, implicate the α4-β5-α5
interface for dimerization [23].
In this study, we investigated the role of Met13 in the
phosphorylation-induced dimerization and binding of
VraR to its own promoter. Our in vitro and in vivo stud-
ies revealed the profound effect that this single amino
acid residue has on the cell-wall antibiotic stress re-
sponse in S. aureus. In addition, they validated the sig-
nificance of inhibition of the phosphorylation-induced
activation of VraR in re-sensitizing S. aureus to β-
lactams and vancomycin.
Results
Characterization of the VraRM13A variant
The VraRM13A variant was purified to homogeneity as de-
scribed before [14]. To assess the impact of substitution of
Met13 by Ala on the overall secondary structures and the
structural integrity of VraR, we recorded the CD spectrum
of the VraRM13A variant and its thermal melting, respect-
ively, and compared these data against the wild-type protein
CD spectrum and the thermal melting. The CD spectra of
VraR and VraRM13A were similar, indicating that the sub-
stitution of Met by Ala did not have a deleterious effect on
the secondary structural features of the protein (see Add-
itional file 1: Figure S1A). This outcome was to be expected
as Met-13 residue sits on an α-helix (α1) and its substitute,
alanine, is a strong α-helix former [24]. The thermal melt-
ing studies also showed that the stability of the variant pro-
tein was similar to that of the wild-type protein, inferring
that the overall integrity of the protein was not affected (see
Additional file 1: Figure S1B).
Phosphorylation of VraRM13A
Phosphorylation of VraR and VraRM13A by a small
molecule donor such as acetyl phosphate was assessed
by Phos-tag™ SDS-PAGE: the un-phosphorylated and
phosphorylated protein species were separated by the
SDS-PAGE as a result of the phosphorylated species mo-
bility being slowed down by the Phostag reagent in the
SDS-PAGE (Fig. 3). The protein bands, stained with coo-
massie blue, were quantified by ImageJ (NIH). These ex-
periments showed that after 45min of incubation the
VraRM13A variant underwent about 10% phosphorylation
compared to 73% of phosphorylation measured for VraR.
Oligomerization state of VraRM13A
Earlier studies on VraR have shown that phosphoryl-
ation drives the protein, otherwise a monomer, toward
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dimerization [14]. The Met-13 residue was identified as
one of the residues that participated intimately in
dimerization (Fig. 2) [16]. Hence, reduction of the me-
thionine side chain to that of a methyl group should
have an impact on the dimerization. The native-PAGE
experiments were performed to investigate the protein
dimerization ability after attempting the phosphoryl-
ation. The VraRM13A variant, subjected to the phos-
phorylation, did not form a dimer at 10 μM, 20 μM or
30 μM (or 40 μM, data not shown), unlike VraR (Fig. 4).
Analysis of the DNA-binding activity of VraR
To evaluate the DNA-binding activity of VraRM13A, we
performed DNase I footprinting experiments. Previous
studies showed that unphosphorylated VraR binds to the
region − 50 to − 75 (namely R1) of the vrasR promoter
(PVraSR) while phosphorylated VraR (VraR-P) binds to an
additional site of the promoter, the region − 46 to − 26
(namely R2), (Fig. 1b) [15]. The DNase I footprinting exper-
iments carried out with VraRM13A showed that unpho-
sphorylated and acetyl phosphate-treated VraRM13A
bound to PVraSR in the same way as unphosphorylated VraR
(Fig. 5); only the R1 was occupied by these proteins, not the
R2 site. These results are in agreement with the outcome of
the phosphorylation and oligomerization experiments,
which showed that VraRM13A subjected to phosphoryl-
ation with acetyl phosphate failed to undergo quantitative
phosphorylation and any measurable dimerization. We
A
B
Fig. 1 Schematic views of the signal transduction pathway mediated by VraSR (a) and of the VraR-bindinding sites on the vraSR promoter (b)
Fig. 2 The dimerization interface as resolved by X-Ray
crystallography (PDB ID: 4IF4)
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analyzed the band intensities of three of the DNA bands
observed in the VraR-protected region of PVraSR by ImageJ,
and compared the DNA binding affinity of VraRM13A to
that of VraR (see Additional file 2: Figure S2). The binding
isotherms show that binding of VraRM13A to the R1 site
of PVraSR was weaker than binding of VraR. We had shown
earlier that the VraR DNA-binding sequence consists of
two in-tandem sequences which in R1 are very close to
each other, separated by one nucleotide, and as such they
are likely to promote dimerization of VraR in this site [17].
The weaker DNA-binding observed for VraRM13A, in
comparison to VraR, could be due to the inability of
VraRM13A to engage into a dimer at the R1 site.
Activation of the vraR regulon in the presence of
vraRM13A
To assess in vivo the effect of the Met13 to Ala substitution
on the activity of VraR, we generated the PvraSR::vraRM13A
construct and cloned it into the shuttle vector pMK4 [25].
The vector pMK4::PvraSRvraRM13A complemented the
RN4220ΔvraR strain well as assessed by measuring the
Fig. 3 Time-dependence phosphorylation of VraR and VraRM13A (M13A) by acetyl phosphate. Coomassie blue staining of the Phostag 12.5%
SDS-PAGE. The experimental conditions were as follows: VraR at 20 μM concentration was incubated with 50mM acetyl phosphate in PB buffer at
37 °C at different time intervals
Fig. 4 Coomassie blue staining of the 10% Native-PAGE of VraR and VraRM13A (M13A) phosphorylated by acetyl phosphate (AP). Briefly, VraR at
the concentrations denoted in the figure was phosphorylated by 50 mM acetyl phosphate in the PB buffer for 1 h, at 37 °C
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expression levels of vraR in the absence and presence of
oxacillin using RT-qPCR (data not shown).
In the current study, we selected a few genes from
the vraR regulon to assess the effect of the Met to
Ala substitution into the transcriptional activity of
VraR. These genes were fmtA, sgtB and pbpB [6]. Ex-
pressions of these genes in the absence of oxacillin
were compared to their respective gene expressions
upon exposure of RN4220ΔvraR(pMK4::PvraSRvraRM1
3A) to sub-inhibitory concentration of oxacillin, for
30 min (data not shown). In all the cases, the comple-
mentation of RN4220ΔvraR with vraRM13A variant
failed to increase gene expression of vraR, fmtA, sgtB
and pbpB in response to oxacillin. The lack of upregu-
lation of the above genes in the presence of oxacillin is very
likely due to the failure of vraRM13A to be induced by oxa-
cillin in the RN4220ΔvraR(pMK4::PvraSRvraRM13A) strain.
Discussion
Substitution of a single residue in VraR, Met13 to Ala, led
to the inability of VraR to undergo quantitative phosphor-
ylation by small molecule donors such as acetyl phosphate
and to dimerize in vitro. In vivo, complementation of the
RN4220ΔvraR strain with vraRM13A did not lead to a re-
sponse to oxacillin-induced stress. We had earlier sug-
gested that the dimerization domain in VraR is located at
the regulatory domain [14]. The X-ray crystal structure of
the VraR dimer showed that the dimerization interface in
the active VraR species (BeF3−-VraR bound species) is lo-
cated at the regulator domain of VraR [16]. Peculiarly, at
the center of this dimerization interface was the side chain
of Met13, sitting on the α1 helix and snugly fitted into a
hydrophobic pocket formed on the opposing molecule of
VraR in the dimer [16]. In this study, we show that substi-
tution of Met13 with Ala does not have measurable effects
on the overall VraR structural integrity as assessed by CD.
Thus, any impact on the activity of VraMet13Ala was at-
tributed to the lack of the methionine-13 side chain.
Autophosphorylation of VraRM13A by a small mol-
ecule phosphodonor such as acetyl phosphate was about
7-fold less compared to the wild-type protein. We attrib-
uted this outcome to the inability of VraRM13A to
dimerize in the absence of the methionine sidechain.
Dimerization is considered to be a process that drives
forward phosphorylation of RR [26]. The aspartyl phos-
phate species carry a high negative free energy and
dimerization can channel that energy in the form of con-
formational changes in the protein. These conform-
ational changes, which mark activation of RR, facilitate
binding of RR to itself (oligomerization) and/or the tar-
get DNA sequence or other proteins [26]. So if
dimerization is impeded, the phosphorylation of RR will
also be affected (Fig. 6). This explains the slower phos-
phorylation rate of VraM13A and highlights the signifi-
cance of the Met-13 residue in dimerization of VraR.
Phosphorylation of VraR is required for upregulation
of its own operon, the vraSR operon [15, 17]. We had
shown earlier that phosphorylation-induced dimerization
of VraR is required to bind to a lesser conserved DNA-
binding site on the vraSR promoter, namely the R2
site (Fig. 1b); while a conserved DNA-binding site,
namely the R1 site, in the same promoter, can recruit
Fig. 5 DNase I footprinting experiment. The top strand of PvraSR was
labelled with 32P at the 5′-end, and incubated with VraR, VraR-P,
VraMet13Ala (M13A), and VraRM13A subjected to phosphorylation
with acetyl phosphate. The sample were each protein was absent
from the reaction mixture is denoted by C
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the unphosphorylated VraR protein (Fig. 1b). In the case
of VraRM13A, the DNase I footprinting experiments
showed that subjection of this variant protein to phos-
phorylation did not lead to binding to the R2 site even
at protein concentrations as high as 50 μM. However,
the conserved DNA-binding site, the R1 site, was occu-
pied by VraRM13A. This result confirms our earlier
work that dimerization of VraR is required for recogni-
tion of a DNA-binding site that is less conserved [17].
The significance of dimerization in gene activation by
VraR was corroborated by the RT-qPCR experiments.
Indeed, the wild-type vraR gene was able to complement
the RN4220ΔvraR strain, and mediate the vraR regulon
in the presence of oxacillin, as indicated by the increased
in the expression levels of the fmtA, sgtB and pbpB
genes. However, complementation of the RN4220ΔvraR
strain with vraRM13A failed to mediate the vraR regu-
lon in the presence of oxacillin, as indicated by the lack
thereof of upregulation of the above genes. This observa-
tion is very likely due to the lack of upregulation of the
vraSR operon in the presence of oxacillin. VraR is
known to regulate its own operon, hence if VraRM13A
is not able to bind to its own promoter optimally it will
not lead to higher expression levels of vraR in the pres-
ence of stress, and subsequently VraR cannot regulate
its target genes.
Conclusions
The impacts of substitution of Met13 with Ala on the
phosphorylation rate, dimerization and gene activation
by VraR demonstrates the significance of this residue
in driving the phosphorylation-induced activation of
VraR, and hence cell wall stress response in S. aur-
eus. As such, targeting the dimerization interface in
VraR, and possibly in other response regulators of the
NarL/FixJ family, through small molecules is a strat-
egy that can efficiently disrupt the signal transduction
mechanism of bacterial response to their respective
stimuli. In addition, due to their conservative nature,
inhibition of RR offers a global strategy in targeting a
wide range of pathogens. Furthermore, RRs offer a
unique and a direct site of inhibition in TCSs; in the
past, inhibition of HK did not lead to inactivation of
RR due to the ability of RR to cross-talk with other
phosphate-donors in the cell and by-pass the histidine
kinase [4].
Methods
Chemicals, growth media, and antibiotics were purchased
from Thermo-Fisher (Whitby, Canada) or Sigma (Oakville,
Canada), unless otherwise stated. Escherichia coli strains,
such as NovaBlue and BL21(DE3), and other expression
plasmids were purchased from EMD4 Biosciences (New
Jersey, USA). All the primers were purchased from Sigma
(Oakville, Canada). Chromatography columns and media
were bought from GE Healthcare (Mississauga, ON, CA).
Radioactive [γ-32P]-ATP was purchased from Perkin Elmer
(Life and Analytical Sciences, Waltham, MA, USA).
Generation of the vraRM13A variant, production and
purification of the VraRM13A protein
The vraRM13A variant was generated through site di-
rected mutagenesis using the QuikChange Site-Directed
Mutagenesis kit (Agilent). The nucleic acid sequences of
Fig. 6 The schematic view of the structural rearrangements that take place upon VraR-P dimerization that lead to the activation of the protein
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the mutagenic primers used in these experiments were
as follows: Dir: 5′-GTGGATGATCATGAAGCGGTAC
GTAT AG, Rev.: 5′-CTATACGTACCGCTTCATGAT-
CATCCAC. The pET26b::vraR vector [14] was amplified
using the above mutagenic primer pair as suggested by
the vendor. The resulting amplicon was subjected to di-
gestion by DpnI and then used to transform E. coli
NovaBlue. Mutation was confirmed by DNA sequencing
at the Centre for Applied genomics (TCAG) facilities
(Sick Kid’s Hospital). The mutated pET26b::vraRM13A
vector was introduced into the expression host E. coli
BL21(DE3). The induction, isolation and purification of
VraRM13A variant were carried out similarly to that of
the wild-type protein, and as described by [14].
Circular dichroism (CD) spectroscopy and thermal melting
of VraRM13A
The CD spectrum of the target protein was carried out
by preparing a protein solution of 10 μM in 20 mM Tris,
pH 7.0 buffer, and supplemented with 5 mM MgCl2. The
CD spectrum was recorded from 200 to 260 nm in a
Jasco J-810 instrument (0.1 cm path length cuvette). To
investigate the effect of the mutation on the overall
structure of the protein, the thermal melting of the pro-
tein was carried out by monitoring the CD signal at 222
nm from 20 °C to 100 °C in a Jasco J-810 instrument.
Phosphorylation of VraR by lithium potassium acetyl
phosphate
Phosphorylation of VraR, or VraM13A variant (10 μM
or 20 μM), was carried out with 50 mM acetyl phos-
phate in the phosphorylation buffer (1X PB: 50 mM
Tris, pH 7.4 buffer, 50 mM KCl, 20 mM MgCl2). The
reaction mixtures were incubated for up to 1 h at 37 °C.
The extent of protein phosphorylation was evaluated by
Phos-tag™ 12.5% SDS polyacrylamide gel electrophor-
esis (PAGE) [27].
Examination of the oligomerization state of VraR and
VraM13A by native-PAGE
Dimerization of VraR and its variant upon phosphoryl-
ation was examined by native-PAGE. Briefly, the protein
at concentrations 10 μM, 20 μM, and 30 μM was phos-
phorylated as described above and samples were re-
solved into a 10% native-PAGE at 4 °C.
DNase I footprinting assay
To perform this assay the region − 121 to + 26 of the
vraSR promoter (PvraSR) was amplified by PCR using a
32P -5′-end direct primer Dir: 5′-ACGAAGCTTGG
TCCGATTTTAACGAC AAAAATTG-3′ and a reverse
primer Rev: 5′-TGAAATGACGCATTGATTGTGTTC-
3′ [15]. The amplicon (2 ng) was incubated with VraR,
phosphorylated VraR (VraR-P), VraRM13A and VraRM
13A subjected to phosphorylation (VraRM13A/P) at dif-
ferent concentrations (0, 2, 5, 25, and 50 μM) in the bind-
ing buffer (10mM Tris, pH 7.5 buffer, 50mM KCL, 1mM
DTT) supplemented with 10mM MgCl2, 50% glycerol
and 20 ng/μl Herring sperm DNA. Each binding reaction
was subjected to DNase I for 2min to digest the DNA and
then the DNase I stop solution (1% SDS, 0.2M NaCl, 20
mM EDTA, pH 8.0) to stop the reaction. Samples were re-
solved by an 8% polyacrylamide gel containing urea, and
the DNA bands were visualized using a Typhoon Trio+
Variable Mode Imager (GE HealthCare).
Construction of the complementing vector,
pMK4::PvraSRvraR
In these experiments, the vraSR promoter region from
− 121 to + 150 (PvraSR) was fused to the vraR gene
(PvraSR::vraR) and the entire sequence was cloned into
the pMK4 shuttle vector in order to complement the S.
aureus ΔvraR strain and assess the effect of the M13A
substitution into the VraR activity in vivo, by RT-qPCR.
Briefly, PvraSR was amplified using the primer pair Dir:
5’AGGAATTCGGTCCGATTTTAACGACAAAAATTG
and Rev.: 5’CGGGATCCAC GTTCAACATAGTTCA-
TAAC (the underlined regions represent the sequences
of the restriction enzyme sites, EcoRI and BamHI re-
spectively) and the vraR gene was amplified using the
primer pair Dir: 5’CGGGATCCATGACGATTAAAG-
TATTGTTTG and Rev.: 5’GCGTCGACCTAT TGAA
TTAAATTATGTTG (the underlined regions represent
the sequences of the restriction enzyme sites, BamHI
and SalI respectively). The PvraSR::vraR construct was li-
gated into the pMK4 vector at the EcoRI and SalI re-
striction sites. The sequence of the construct was
confirmed by DNA sequencing. The pMK4::PvraSRvraR
plasmid was introduced to S. aureus RN4220ΔvraR
competent cells by electroporation (2 kV, 2.5 ms) using
Micropulser (Bio-Rad) and were grown on TSB agar
supplemented by 10 μg/ml chloramphenicol. Introduc-
tion of the mutation on the vraR gene at the pMK4::
PvraSRvraR plasmid was carried out by site-directed mu-
tagenesis as outlined above.
RT-qPCR to investigate expression of the vraR regulon
genes in the RN4220ΔvraR strain complemented with
vraRM13A
An overnight seed culture of one of the RN4220 strains
was prepared in TSB media supplemented by 10 μg/ml
chloramphenicol. An aliquot of 160 μl of overnight seed
culture were used to inoculate 16 ml TSB medium sup-
plemented with 10 μg/ml chloramphenicol. The subse-
quent culture was incubated at 37 °C (200 rpm) up to an
optical density at 600 nm (OD600) of 0.4. The culture
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was split into two 5ml aliquots and one of them was
treated with 10 μg/ml oxacillin which was incubated
along with the control sample, namely the non-oxacillin
treated sample, at 37 °C for 30 min. An aliquot of 1 ml
growth culture was used to isolate RNA using the
RNeasy Mini kit (Qiagen) as per vendor’s instructions.
High Capacity RNA-to-cDNA kit (Life Technolo-
gies) was used to synthesize cDNA from 500 ng of
DNase I treated RNA. The 16 s RNA gene was used
as an internal control using designed primers: Dir-
5’GCTAAGTGTTAGGGGGTTTCC and Rev-5’TTCA
ACCTTGCGGTCGTACT. The 20 μl reaction mix-
tures consisted of 25 ng of cDNA, 0.25 μM of each
primer (accordingly designed to target specific gene,
Table 1), and 10 μl of SYBRE SELECT Master Mix
(Life Technologies). The Rotor-gene Q qRT-PCR cycler
(Qiagen) was used to amplify the cDNA. The PCR condi-
tions were as follows: First hold: 2 min at 50 °C, second
hold:10min for 95 °C, 40 cycles of 95 °C for 15 s, 60 °C for
30 s, and 72 °C for 30min; and 72 °C for 10min as a final
extension step. The sequences of the primers that were
used to probe the expression of genes such as vraR, fmtA,
sgtB and pbpB are provided in Table 1.
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